NDC 0061-4363-02 - Banamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-4363
- Requested NDC
- 0061-4363-02
- Package NDCs from labels
- 0061-4363-01, 0061-4363-02, 0061-4363-03
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2026-02-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Banamine ® Transdermal (flunixin transdermal solution) | Merck Sharp & Dohme Corp. | 2026-02-19 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-4363-01 | Banamine | 1 in 1 CARTON | SOLUTION | 1 | 4 | |
| 0061-4363-01 | Banamine | 100 mL in 1 BOTTLE, PLASTIC | SOLUTION | 100 | 4 | |
| 0061-4363-02 | Banamine | 1 in 1 CARTON | SOLUTION | 1 | 4 | |
| 0061-4363-02 | Banamine | 250 mL in 1 BOTTLE, PLASTIC | SOLUTION | 250 | 4 | |
| 0061-4363-03 | Banamine | 1 in 1 CARTON | SOLUTION | 1 | 4 | |
| 0061-4363-03 | Banamine | 1000 mL in 1 BOTTLE, PLASTIC | SOLUTION | 1000 | 4 |
DailyMed Dashboard NDC Coverage#
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.